Localization of lymphatic leakage site in chylothorax by thoracic duct scintigraphy by orally administered 123I BMIPP using SPECT/CT

Kentaro Takanami, Hirofumi Ichikawa, Shoki Takahashi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A 58-year-old man with chylothorax after graft replacement of the aortic arch underwent thoracic duct scintigraphy by orally administered 123I-labeled 15-(4-iodophenyl)-3(R,S)-methylpentadecanoic acid with single-photon emission computed tomography combined with computed tomography (SPECT/CT). SPECT/CT fusion image clearly showed the increased uptake near the vascular anastomotic site of the aortic arch. Therefore, a chylothorax due to a traumatic rupture of a thoracic duct was suspected. This report indicates the clinical usefulness of thoracic duct scintigraphy by orally administered 123I-labeled 15-(4-iodophenyl)-3(R,S)-methylpentadecanoic acid using SPECT/CT for the localization of the lymphatic leakage site in chylothorax.

Original languageEnglish
Pages (from-to)403-405
Number of pages3
JournalClinical Nuclear Medicine
Volume37
Issue number4
DOIs
Publication statusPublished - 2012 Apr

Keywords

  • BMIPP
  • SPECT/CT
  • chylothorax
  • lymphoscintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Localization of lymphatic leakage site in chylothorax by thoracic duct scintigraphy by orally administered <sup>123</sup>I BMIPP using SPECT/CT'. Together they form a unique fingerprint.

Cite this